News   Publication   Financial Report
	News
	2011/12/16 AbGenomics International Inc Regains Global Rights to AbGn-168H from Boehringer Ingelheim 2009/03/03 AbGn-168 Phase I Trial Initiate 2005/06/06 Boehringer Ingelheim and Abgenomics Corporation Sign License  Agreement to Develop and Commercialize a Therapeutic Monoclonal Antibody 2002/06/24 R&D focus, AbGenomics Corporation News 2002/06/03 AbGenomics Corporation to Be Featured at BIO 2002 Business Forum 2001/12/21 The China Post, NTUCM to work with biotech firm 2001/12/03 Reuters, Taiwan's AbGenomics Eyes Global Partnerships
Copyright. AbGenomics Corporation. All Rights Reserved. Disclaimer